Jeonjin Biofarm Co., Ltd. (110020) - Financials, balance sheet (annual)

4,095 KRW

680

19.91%

Last update Jun 5, 3:00 PM KST

Market closed

Day range

4,095

3,510

4,400

Previous close

3,415

Open

3,660

Access this stock data via API

Jeonjin Biofarm Co., Ltd.

4,095.00

680

19.91%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	18.9B	17.7B	17.9B	24.8B
Current assets	10.1B	7.8B	4.8B	16.2B
Cash	6.3B	1.7B	1.3B	15.3B
Cash equivalents	—	—	—	—
Cash and cash equivalents	6.3B	1.7B	1.3B	15.3B
Other short term investments	472.5M	—	—	—
Accounts receivable	2.5B	2.8B	724.0M	205.0M
Other receivables	2.8M	1.5B	606.0M	4.2M
Inventory	921.3M	1.7B	2.0B	602.3M
Prepaid assets	20.1M	25.3M	109.9M	40.8M
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	-710	970	-430	260
Non current assets	8.7B	9.9B	13.2B	8.7B
Properties	1.1B	2.5B	2.5B	90.5M
Land and improvements	3.0B	3.0B	3.0B	3.0B
Machinery furniture equipment	4.0B	4.3B	3.4B	2.1B
Construction in progress	78M	268M	545.6M	—
Leases	—	—	—	—
Accumulated depreciation	-3.1B	-3.8B	-2.1B	-831.4M
Goodwill	21.8M	71.9M	717.5M	610.4M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	21.8M	71.9M	717.5M	610.4M
Investments and advances	—	—	—	—
Other non current assets	10	10	10	10
Total liabilities	1.2B	11.5B	8.4B	14.0B
Current liabilities	1.1B	11.2B	7.9B	14.0B
Accounts payable	260.1M	239.7M	139.2M	47.8M
Accrued expenses	—	—	—	—
Short term debt	92.6M	5.6B	5.7B	7.4B
Deferred revenue	—	—	—	—
Tax payable	166.9M	153.0M	—	11.9M
Pensions	—	—	—	—
Other current liabilities	16.5M	82.5M	71.8M	43.2M
Non current liabilities	105.7M	271.3M	411.9M	42.3M
Long term provisions	—	—	45.3M	—
Long term debt	—	—	288.3M	—
Provision for risks and charges	—	43.5M	18.1M	41.2M
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	530	270	230
Shareholders equity
Common stock	4.5B	3.7B	3.4B	3.2B
Retained earnings	-28.1B	-32.4B	-25.9B	-22.9B
Other shareholders equity	—	—	—	—
Total shareholders equity	17.7B	6.2B	9.6B	10.8B
Additional paid in capital	42.3B	35.6B	33.0B	31.4B
Treasury stock	—	—	—	—
Minority interest	—	—	—	—